Quinn Opportunity Partners LLC acquired a new stake in shares of Rentokil Initial PLC (NYSE:RTO – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 42,105 shares of the company’s stock, valued at approximately $1,011,000.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Parallel Advisors LLC increased its stake in Rentokil Initial by 416.9% during the 2nd quarter. Parallel Advisors LLC now owns 1,132 shares of the company’s stock worth $27,000 after buying an additional 913 shares during the period. IFP Advisors Inc grew its stake in shares of Rentokil Initial by 115.5% during the second quarter. IFP Advisors Inc now owns 1,282 shares of the company’s stock valued at $31,000 after acquiring an additional 687 shares in the last quarter. Brooklyn Investment Group increased its position in shares of Rentokil Initial by 668.3% during the first quarter. Brooklyn Investment Group now owns 1,598 shares of the company’s stock worth $37,000 after acquiring an additional 1,390 shares during the last quarter. State of Wyoming acquired a new position in shares of Rentokil Initial in the first quarter worth about $46,000. Finally, Cape Investment Advisory Inc. boosted its holdings in Rentokil Initial by 67.4% in the first quarter. Cape Investment Advisory Inc. now owns 2,519 shares of the company’s stock valued at $58,000 after purchasing an additional 1,014 shares during the last quarter. 9.91% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the company. Berenberg Bank raised Rentokil Initial to a “strong sell” rating in a research report on Monday, September 29th. Jefferies Financial Group raised shares of Rentokil Initial to a “strong-buy” rating in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Rentokil Initial in a research note on Monday, July 21st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Rentokil Initial in a research note on Wednesday, October 8th. Finally, Sanford C. Bernstein raised Rentokil Initial from an “underperform” rating to an “outperform” rating in a report on Tuesday, October 7th. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.
Rentokil Initial Stock Down 0.2%
Shares of NYSE RTO opened at $26.68 on Thursday. Rentokil Initial PLC has a 1-year low of $19.60 and a 1-year high of $30.10. The business’s fifty day moving average price is $26.40 and its two-hundred day moving average price is $24.75.
Rentokil Initial Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Stories
- Five stocks we like better than Rentokil Initial
- What is the Shanghai Stock Exchange Composite Index?
- 3 Reasons On Holding’s Sell-Off Is Over and New Highs Are Coming
- What is the S&P 500 and How It is Distinct from Other Indexes
- As Warren Buffett Nears His Exit, Berkshire’s Amassed Record Cash
- 3 Warren Buffett Stocks to Buy Now
- Rare Earth Stocks: The Truce That Isn’t a Truce
Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial PLC (NYSE:RTO – Free Report).
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
